Results 261 to 270 of about 94,071 (310)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 2005
Warfarin or not warfarin? That is the question.Each day, physicians who treat elderly patients, especially octogenar-ians, consider this dilemma. Benefits of warfarin are well known inpatients 75 years of age or older. However, compared with youngerpatients, this group is at higher risk for intracranial hemorrhage andother types of warfarin-associated ...
Margaret C. Fang, Daniel E. Singer
openaire +2 more sources
Warfarin or not warfarin? That is the question.Each day, physicians who treat elderly patients, especially octogenar-ians, consider this dilemma. Benefits of warfarin are well known inpatients 75 years of age or older. However, compared with youngerpatients, this group is at higher risk for intracranial hemorrhage andother types of warfarin-associated ...
Margaret C. Fang, Daniel E. Singer
openaire +2 more sources
Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, 2010 Background— Although warfarin is widely recommended to prevent atrial fibrillation-related thromboembolism, many eligible patients do not take warfarin. The objective of this study was to describe factors associated with warfarin
Margaret C Fang +2 more
exaly +2 more sources
Pediatric Pathology & Molecular Medicine, 2003
A 34-year-old gravida 2 para 1 (1001) mother was on prophylactic anticoagulation therapy because of pulmonary emboli postabdominal surgery. The pregnancy was terminated at 25 weeks' gestation after ultrasound examination showed a mild hydrocephalus and a cardiac structural defect.
Kiat Yeong, Chan +2 more
openaire +2 more sources
A 34-year-old gravida 2 para 1 (1001) mother was on prophylactic anticoagulation therapy because of pulmonary emboli postabdominal surgery. The pregnancy was terminated at 25 weeks' gestation after ultrasound examination showed a mild hydrocephalus and a cardiac structural defect.
Kiat Yeong, Chan +2 more
openaire +2 more sources
Archives of Family Medicine, 1992
Skin and subcutaneous tissue necrosis is a rare complication of warfarin therapy. Although the incidence is low, with increased use of warfarin family physicians need to be aware of this potentially catastrophic event. This article reviews the history of warfarin necrosis and discusses its clinical presentation.
J T, McKnight +2 more
openaire +2 more sources
Skin and subcutaneous tissue necrosis is a rare complication of warfarin therapy. Although the incidence is low, with increased use of warfarin family physicians need to be aware of this potentially catastrophic event. This article reviews the history of warfarin necrosis and discusses its clinical presentation.
J T, McKnight +2 more
openaire +2 more sources
Annals of Internal Medicine, 1982
Excerpt To the editor: The information in the recent letter by Krauss (1) is misleading on three counts and calls for a response.
openaire +2 more sources
Excerpt To the editor: The information in the recent letter by Krauss (1) is misleading on three counts and calls for a response.
openaire +2 more sources
Archives of Pediatrics & Adolescent Medicine, 1975
A remarkable syndrome of congenital anomalies has been described in recent years, which has been tentatively attributed to maternal consumption of warfarin sodium (Coumadin) throughout pregnancy. One case reported by Kerber et al 1 in 1968 described pregnancy in a patient with a prosthetic valve, associated with a fetal anomaly ascribed by the authors ...
openaire +2 more sources
A remarkable syndrome of congenital anomalies has been described in recent years, which has been tentatively attributed to maternal consumption of warfarin sodium (Coumadin) throughout pregnancy. One case reported by Kerber et al 1 in 1968 described pregnancy in a patient with a prosthetic valve, associated with a fetal anomaly ascribed by the authors ...
openaire +2 more sources
Annual Review of Medicine, 2010
Warfarin is a drug with a narrow therapeutic index and a wide interindividual variability in dose requirement. Because it is difficult to predict an accurate dose for an individual, patients starting the drug are at risk of thromboembolism or bleeding associated with underdosing or overdosing, respectively.
Kamali F, Wynne H
openaire +3 more sources
Warfarin is a drug with a narrow therapeutic index and a wide interindividual variability in dose requirement. Because it is difficult to predict an accurate dose for an individual, patients starting the drug are at risk of thromboembolism or bleeding associated with underdosing or overdosing, respectively.
Kamali F, Wynne H
openaire +3 more sources
Warfarin and Warfarin‐Alcohol Levels in Anticoagulated Patients
Australian and New Zealand Journal of Medicine, 1979Summary: The relationship between dosage, prothrombin ratio, and steady‐state plasma concentrations of warfarin and warfarin‐alcohol, were determined in 43 patients regularly attending an anticoagulant clinic.The warfarin and warfarin‐alcohol concentrations were determined by a gas chromatographic mass spectroscopic (GC/MS) method.
P, Duffield +4 more
openaire +2 more sources
Annals of Internal Medicine, 1973
Excerpt To the editor: A recent article by O'Reilly (1) has a misleading statement in the abstract: "An augmentation of the therapeutic effect of a drug by disulfiram has thus been shown for the fi...
openaire +2 more sources
Excerpt To the editor: A recent article by O'Reilly (1) has a misleading statement in the abstract: "An augmentation of the therapeutic effect of a drug by disulfiram has thus been shown for the fi...
openaire +2 more sources
To Warfarin or Not to Warfarin, That Is the Question!
A56. MISSION: CASE REPORTS IN THROMBOEMBOLIC DISEASE, 2022A. Soni +5 more
openaire +1 more source